Patents by Inventor Yong Xu

Yong Xu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030100052
    Abstract: The present invention relates to recombinant DNA that encodes the BsmBI restriction endonuclease as well as BsmBI methyltransferase, expression of BsmBI restriction endonuclease and BsmBI methylase in E. coli cells containing the recombinant DNA. It also relates to a method for purification of the recombinant BsmBI restriction endonuclease.
    Type: Application
    Filed: September 28, 2001
    Publication date: May 29, 2003
    Applicant: New England Biolabs
    Inventors: Shuang-Yong Xu, Andrew Dore, Adam Hume, John Pelletier, Jing Zhou
  • Patent number: 6514737
    Abstract: The present invention relates to recombinant DNA which encodes the AsiSI restriction endonuclease as well as AsiSI methylase, expression of AsiSI restriction endonuclease and AsiSI methylase in E. coli cells containing the recombinant DNA.
    Type: Grant
    Filed: August 20, 2001
    Date of Patent: February 4, 2003
    Assignee: New England Biolabs, Inc.
    Inventors: Zhenyu Zhu, Shuang-yong Xu
  • Patent number: 6440715
    Abstract: The present invention provides a novel thermostable DNA polymerase I obtainable from Rhodothermus obamensis, which possesses 3′-5′ exonuclease activity and has a half-life of about 35 minutes at 94° C. This polymerase also contains a tyrosine residue in the ribosome binding site which improves incorporation of dideoxyribonucleic acids. Also provided are isolated DNA and vectors encoding this polymerase, as well as its large fragment, and methods for producing recombinant enzyme using the same.
    Type: Grant
    Filed: March 12, 1999
    Date of Patent: August 27, 2002
    Assignee: New England Biolabs, Inc.
    Inventor: Shuang-yong Xu
  • Patent number: 6413758
    Abstract: The present invention relates to recombinant DNA which encodes the BpmI restriction endonuclease as well as BpmI methyltransferase, expression of BpmI restriction endonuclease from E. coli cells containing the recombinant DNA. BpmI endonuclease is a fusion of two distinct elements with a possible structural domains of restriction-methylation-specificity (R-M-S). This domain organization is analogous to the type I restriction-modification system with three distinct subunits, restriction, methylation, and specificity (R, M, and S). Because BpmI is quite distinct to other type IIs restriction enzymes, it is proposed that BpmI belongs to a subgroup of type II restriction enzymes called type IIf (f stands for fusion of restriction-modification-specificity domains). The Type IIf group of restriction enzyme includes Eco57I, BpmI, GsuI, BseRI and some other restriction enzymes that cut downstream sequences at long distance, 10-20 bp downstream of recognition sequence, such as MmeI (N20/N18)).
    Type: Grant
    Filed: October 20, 2000
    Date of Patent: July 2, 2002
    Assignee: New England Biolabs, Inc.
    Inventors: Shuang-yong Xu, Jian-ping Xiao, Zhenyu Zhu
  • Patent number: 6403354
    Abstract: The present invention relates to recombinant DNA which encodes the BstYI restriction endonuclease as well as BstYI methyltransferase, expression of BstYI restriction endonuclease and M.BstYI in E. coli cells containing the recombinant DNA. It also relates to methods for purification of the recombinant BstYI restriction endonuclease and BstYI methyltransferase.
    Type: Grant
    Filed: January 19, 2001
    Date of Patent: June 11, 2002
    Assignee: New England Biolabs, Inc.
    Inventors: Shuang-yong Xu, James Samuelson, John Pelletier, Marion Sibley, Geoffrey G. Wilson
  • Patent number: 6387681
    Abstract: The present invention relates to recombinant DNA which encodes the NheI restriction endonuclease as well as NheI methyltransferase, expression of NheI restriction endonuclease from E. coli cells containing the recombinant DNA. An internal NdeI site in the nheIR gene was eliminated by a silent mutation. A new NdeI site was engineered at the start codon of nheIR gene. An NdeI-BamHI fragment containing nheIR gene was cloned into a T7 expression vector pAII17 and expressed in a premodified host ER2566 [pACYC-NheIM, pAII17-NheIR2]. The recombinant clone produces approximately 10 million units of NheI per gram of wet cells.
    Type: Grant
    Filed: October 28, 1999
    Date of Patent: May 14, 2002
    Assignee: New England Biolabs, Inc.
    Inventors: Shuang-yong Xu, Jian-ping Xiao
  • Publication number: 20020053242
    Abstract: A surface-micromachined high-pressure sensor, formed by forming a cavity using a sacrificial layer. The sacrificial layer can be reflowed to make the edges of the cavity more rounded. The material that is used for the diaphragm can be silicon nitride, or multiple layers including silicon nitride and other materials. The pressure sensor is intended to be used in high pressure applications, e.g. pressure is higher than 6000, 10,000 or 30,000 P.S.I.
    Type: Application
    Filed: July 6, 2001
    Publication date: May 9, 2002
    Inventors: Yu-Chong Tai, Yong Xu, Fukang Jiang
  • Patent number: 6335190
    Abstract: The present invention relates to recombinant DNA which encodes the BsmI restriction endonuclease as well as BsmI methyltransferases, expression of BsmI restriction endonuclease in E. coil cells containing the recombinant DNA by using a low copy number T7 expression vector pACYC-T7ter, and purification of BsmI restriction endonuclease by heat treatment and chromatography through heparin Sepharose column.
    Type: Grant
    Filed: October 20, 2000
    Date of Patent: January 1, 2002
    Assignee: New England Biolabs, Inc.
    Inventors: Jing Zhou, Zhenyu Zhu, Shuang-yong Xu
  • Publication number: 20010012640
    Abstract: A lens is formed out of semiconductor material. The semiconductor produces light which is coupled to the lens. The lens focuses the light and also minimizes refractive reflection. The lens is formed by a graded aluminum alloy, which is oxidized in a lateral direction. The oxidation changes the effective shape of the device according to the grading.
    Type: Application
    Filed: April 10, 2001
    Publication date: August 9, 2001
    Applicant: California Institute of Technology, California non-profit organization
    Inventors: John O'Brien, Chuan-Cheng Cheng, Axel Scherer, Amnon Yariv, Yong Xu
  • Patent number: 6215134
    Abstract: A lens is formed out of semiconductor material. The semiconductor produces light which is coupled to the lens. The lens focuses the light and also minimizes refractive reflection. The lens is formed by a graded aluminum alloy, which is oxidized in a lateral direction. The oxidation changes the effective shape of the device according to the grading.
    Type: Grant
    Filed: May 8, 1998
    Date of Patent: April 10, 2001
    Assignee: California Institute of Technology
    Inventors: John O'Brien, Chaun-cheng Cheng, Axel Scherer, Amnon Yariv, Yong Xu
  • Patent number: 6207377
    Abstract: The present invention relates to cloned DNA containing origin of DNA replication and to cloned DNA encoding repliation protein, RepT.
    Type: Grant
    Filed: August 14, 1998
    Date of Patent: March 27, 2001
    Assignee: New England Biolabs, Inc.
    Inventors: Jay Wayne, Shuang-yong Xu
  • Patent number: 6133008
    Abstract: A genomic DNA library of Thermus filiformis was constructed using pBR322 as a cloning vector. The methylase selection method was used to clone the TfiI methylase gene (tfiIM). A clone carrying an active TfiI methylase was identified. After sequencing the complete TfiI methylase gene and its downstream DNA sequence, a recombinase homolog was found. Because the methylase and its cognate endonuclease gene are located in proximity to each other in a particular restriction-modification system, efforts were made to clone the upstream DNA by inverse PCR. After two rounds of inverse PCR, one open reading frame (ORF1) was found upstream of the TfiI methylase gene. This ORF1, containing a Shine-Dalgarno sequence and a TATA box on the upstream side, was cloned and expressed, and TfiI endonuclease activity was detected in crude cell extracts. It is concluded that ORF1 encodes TfiI restriction endonuclease.
    Type: Grant
    Filed: May 7, 1999
    Date of Patent: October 17, 2000
    Assignee: New England Biolabs, Inc.
    Inventors: Shuang-yong Xu, Pei-Chung Hsieh
  • Patent number: 6130078
    Abstract: The present invention relates to recombinant DNA molecules encoding NspHI restriction endonuclease and methylase and to method to use premodified E. coli K strain RR1 (.lambda.DE3) for overexpression of NspHI restriction endonuclease.
    Type: Grant
    Filed: November 17, 1998
    Date of Patent: October 10, 2000
    Assignee: New England Biolabs, Inc.
    Inventors: Jian-ping Xiao, Shuang-yong Xu
  • Patent number: 6066487
    Abstract: BsrFI restriction enzyme was purified from Bacillus stearothermophilus to near homogeneity. The protein was sequenced to obtain its N-terminus amino acid sequence. A set of denegerate primers were synthesized based on the aa sequence. The first 18 codons encoding BsrFI restriction endonuclease (bsrFIR) was amplified by PCR and its coding sequence was obtained. The methylase selection method was used to clone BsrFI methylase gene (bsrFIM). Two clones were found to be resistant to BsrFI digstion. The entire insert in one clone was sequenced and the insert encodes the BsrFI methylase (M. BsrFI). In addition, a small truncated open reading frame adjacent to the methylase gene has homology to Cfr10I restriciton endonuclease in a BlastX homology search in Genbank database. BsrFI and Cfr10I are isoschizomer that recognizes and cleaves 5'R CCGGY3'.
    Type: Grant
    Filed: May 7, 1999
    Date of Patent: May 23, 2000
    Assignee: New England Biolabs, Inc.
    Inventors: Shuang-yong Xu, Jian-Ping Xiao
  • Patent number: 6027929
    Abstract: The present invention relates to clones which express the recombinant NspI restriction endonuclease using a NspI methylase premodified E. coli K strain RR1 (.lambda.DE3) and to methods for producing and purifying said enzyme.
    Type: Grant
    Filed: August 18, 1998
    Date of Patent: February 22, 2000
    Assignee: New England Biolabs, Inc.
    Inventor: Shuang-yong Xu
  • Patent number: 6004793
    Abstract: A recombinant restriction endonuclease from Anabaena variabilis is provided, as well as the isolated gene which encodes it and methods for the production of the recombinant AvaI restriction endonuclease. An isolated gene encoding a modification methylase from A. variabilis is also provided.
    Type: Grant
    Filed: August 18, 1998
    Date of Patent: December 21, 1999
    Assignee: New England Biolabs, Inc.
    Inventors: Keith D. Lunnen, Michael A. Dalton, Geoffrey G. Wilson, Shuang-yong Xu
  • Patent number: 5962296
    Abstract: The present invention relates to isolating DNA coding for DNA polymerase I from Thermomicrobium roseum, expressing the T. roseum DNA polymerase I gene in E. coli and purifying the recombinant T. roseum DNA polymerase I from E. coli cell extract.
    Type: Grant
    Filed: February 24, 1998
    Date of Patent: October 5, 1999
    Assignee: New England Biolabs, Inc.
    Inventors: Laurence Ettwiller, Shuang-yong Xu
  • Patent number: 5885818
    Abstract: The present invention relates to recombinant DNA which encodes the AgeI restriction endonuclease as well as AgeI methyltransferase, and production of AgeI restriction endonuclease from E. coli cells containing the recombinant DNA.
    Type: Grant
    Filed: May 14, 1998
    Date of Patent: March 23, 1999
    Assignee: New England Biolabs, Inc.
    Inventors: Shuang-yong Xu, Robert E. Maunus, Keith D. Lunnen, Rachel Allen
  • Patent number: 5866398
    Abstract: The methylase selection method was used to clone the BslI methylase gene (bslIM) from Bacillus species. A partially active BslI methylase lacking the 17 amino acid residues at the N-terminus was cloned in E. coli using expression vector pRRS. Inverse PCR was used to clone the missing portion of the BslI methylase. After cloning the complete BslI methylase gene and its upstream DNA sequences, a RadC homolog was found upstream of the BslI methylase. Because methylase gene and restriction endonuclease gene are located in proximity to each other in a particular restriction-modification system, efforts were made to clone the downstream DNA by inverse PCR. After two round of inverse PCR reactions two open reading frames (ORF) were found downstream of the BslI methylase gene. Expression of the first ORF (ORF1) in a T7 expression vector did not yield any active BslI endonuclease. Expression of the second ORF (ORF2) in E.
    Type: Grant
    Filed: October 17, 1997
    Date of Patent: February 2, 1999
    Assignee: New England Biolabs, Inc.
    Inventors: Shuang-yong Xu, Jian-ping Xiao
  • Patent number: 5866422
    Abstract: The present invention relates to recombinant DNA molecules encoding the Tsp45I gene (tsp45IR), and the cognate M.Tsp45I gene (tsp45IM), from Thermus species YS45 introduced into E. coli as well as expression of the recombinant Tsp45I restriction endonuclease in E coli.
    Type: Grant
    Filed: October 29, 1997
    Date of Patent: February 2, 1999
    Assignee: New England Biolabs, Inc.
    Inventors: Jay Wayne, Shuang-yong Xu